Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com
Elon Musk’s brain tech startup Neuralink has closed a $650 million funding round, the company announced Monday. ARK Invest, Founders Fund, Sequoia Capital, Thrive Capital, Lightspeed Venture Partners and other…
by admin
In this market update, Frank breaks down recent developments across the S&P 500, crypto markets, commodities, and international ETFs. He analyzes bullish and bearish chart patterns, identifies key RSI signals,…
by admin
Trump to host thousands of admin officials for one of the largest events ever on White House lawn
by admin
NEWYou can now listen to Fox News articles! : President Donald Trump on Wednesday evening is hosting the more than 3,000 political appointees in his administration for one of the…
by admin